CL
Insider buying
Chris Lavictoire Mahai bought $10K of abrdn Life Sciences Investors (HQL) stock
Chris Lavictoire Mahai, Dir of abrdn Life Sciences Investors (HQL), bought 527 shares of HQL stock worth $10K, per an SEC Form 4 filed Jul 20, 2026.
It was an open-market purchase.
The trade happened on Jul 16, 2026, 4 days before it was made public.
- Traded
- Jul 16, 2026
- Disclosed
- Jul 20, 2026
- Filing delay
- 4 days
- Role
- Dir
- Source
- SEC Form 4
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.